Sinovac Biotech, Ltd. | TalkMarkets | Page 1
No data available
No data available

People who follow this stock (31)

View All

Latest Posts

About This Stock More About This Stock
Week In Review: Sanofi Acquires Kadmon, A US-China Pharma, For $1.9 Billion
Article By: ChinaBio® Today
Saturday, September 11, 2021 1:30 PM EDT
France's Sanofi will acquire Kadmon Holdings​​ of New York City in a $1.9 billion deal. In 2019, Kadmon formed a JV with BioNova Pharma to develop its novel lead drug, Rezurock (belumosudil) in China.
In this article: SNY, 000963.SZ, SVA, KDMN, 2137.HK, 688177.SS, 1521.HK, 3347.HK, 2126.HK
Read
Week In Review: WHO Close To Approving Global Use For Two China COVID-19 Vaccines
Article By: ChinaBio® Today
Saturday, May 8, 2021 1:00 PM EDT
The World Health Organization approved Sinopharm's COVID-19 vaccine for emergency use, which will give poorer nations access to a vaccine against the pandemic. Sinovac's inactivated COVID-19 vaccine has started to see a rolling review in Europe.
In this article: SHTDF, NVAX, SVA, GLMD, BGNE, TYHT, CVAC
Read
Week In Review: Three China In-Licensing Deals Add Up To $662 Million
Article By: ChinaBio® Today
Saturday, April 3, 2021 2:56 PM EDT
Simcere Pharma of Nanjing announced a $292 million agreement to develop a proposed Kazia Therapeutics treatment for glioma in Greater China. Qihan Biotechnology raised $67 million in a Series A++ round to advance its portfolio of cell therapies.
In this article: SCR, SBMFF, SVA, GILD, BYSI, ZLAB, DCPH, KZIA
Read
Week In Review: JD Health Raises $3.5 Billion In Hong Kong IPO; Climbs 56% On First Day
Article By: ChinaBio® Today
Saturday, December 12, 2020 1:09 PM EDT
JD Health of Guangzhou, the online health-care arm of China e-commerce giant JD.com, completed a $3.5 billion Hong Kong IPO and rose 56% in its first trading session. The company now has a $45 billion market capitalization.
In this article: PFE, IMMP, TCEHY, SVA, BABA, JD
Read
Week In Review: Illumina Pays $8 Billion To Acquire GRAIL, An Early-Stage Cancer Testing Company
Article By: ChinaBio® Today
Saturday, September 26, 2020 1:33 PM EDT
Illumina will acquire Grail, an Illumina spin-out that is developing an early screening test for multiple forms of cancer, for $8 billion in cash and stock. JD Health, a Beijing online healthcare company, plans to raise $3 billion in a Hong Kong IPO.
In this article: ILMN, SVA, ZLAB, LEGN
Read
All Posts

Latest Tweets for $SVA

No tweets yet!

PARTNER HEADLINES